Amgen Inc at Jefferies Global Healthcare Conference in New York Transcript
Good morning. It's still morning. Good morning, everyone. I hope you're doing well. Really pleased to see a packed room and really that goes for right now and also just the entire conference.
My name is Akash Tewari. I head our pharma and biotech efforts here at Jefferies on the research side. And we have Amgen on the panel today. So really excited to have a discussion. I'll hand it off maybe to Peter for opening remarks and we got going.
Great. Thank you, Akash. Good morning, everyone. Great to see you. We are glad to be here. I'm not used to holding the mic -- that's -- all right. So we're just -- we're really glad to be here with you. We appreciate your interest in Amgen and a couple of thoughts for you here before we get going on the Q&A.
We believe there are lots of ways to win [Gramdgen], especially for patients. We're pleased with the strong first quarter performance, which reinforces 2026 as a springboard year
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
